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Previous contributors to this symposium have defined thalassemia in 
clinical and hematological terms. It is obvious that thalassemia presents 
a broad spectrum of abnormalities and that no single hematologic param- 
eter is pathognomic-and, indeed, does not even differentiate all types 
of thalassemia from environmental effects. Thus, until the primary chem- 
ical lesion is precisely defined i t  will be necessary to describe thalassemia 
by patterns of abnormalities. Organization of these patterns upon a genetic 
framework provides an added meaningful dimension to its characteriza- 
tion. Before considering the genetic aspects of thalassemia it may be well 
to  review the genetics of abnormal hemoglobins. 
Most of the inherited abnormalities of human hemoglobin are due to 
substitutions of single amino acid residues among the approximately 140 
residues comprising either the a- or P-polypeptide chains of which the 
normal major hemoglobin component is composed. 1 .2  These reflect small 
errors in the base sequences of the deoxyribonucleic acid of which genes 
are composed. The genetic loci governing the structure of the a- and 
P-polypeptide chains are not closely linked.? The Hba locus, responsible 
for hemoglobin A2 (Hb Aa),  and the HbP structural locus are situated 
at most approximately 10 map units apart on the basis of genetic informa- 
tion available to date? Hemoglobins Lepore and Pylos, hemoglobinopathies 
manifested clinically as thalassemia', J i "  are composed of two normal a- and 
two abnormal non-a-polypeptide chains. The latter have amino acid se- 
quences at the N-terminal portion of the molecule of a-chains and 8-chain 
sequences a t  the carboxyl end of the m~lecule .~ On the supposition that 
this is due to unequal crossing over between the Hba and HbP loci, this 
allows us to orient the two loci with the C-terminal end of the Hba cistron 
close to, but not necessarily adjacent to the N-terminal end of the HbP 
cistron (FIGURE 1). Polypeptide chain synthesis apparently proceeds se- 
quentially from the N-terminus of the chain? There is as yet virtually 
no genetic evidence to locate the Hbv locus for Hb F and this is badly 
needed.O 
The current practice of classifying thalassemia into a- and P-subtypes, 
based upon a combination of chemical and genetic considerations, is po- 
tentially misleading if one loses sight of the types of evidence and the 
assumptions involved. The term P-thalassemia, coined by Ingram and 
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Stretton,'" is given to those thalassemia genes which "interact" with the 
HbP structural mutants in individuals heterozygous for a thalassemia and 
an abnormal hemoglobin gene, resulting in an increase in the abnormal 
hemoglobin to between 70 and 100 per cent of the total hemoglobin from 
the 40 per cent found in the simple heterozygote's blood. Since these 
individuals are usually anemic, this relative increase in the amount of the 
abnormal hemoglobin is due to an absolute decrease in the amount of the 
normal hemoglobin P-polypeptide chains present. In TABLE .1 the offspring 
produced from matings of such double heterozygotes with normal spouses 
are  tabulated. Of these, eight matings are gathered from the published 
literature (summarized in Rucknagel & Nee]:') and four families, all 
Negro, are  from my own laboratory. Of a total of 36 offspring, 16 have 
simple sickle cell trait,  19 have thalassemia minor, and one is questionably 
normal. The normality of the one potential crossover in this series was 
apparently in doubt." This distribution suggests that  the so-called inter- 
acting type of thalassemia is allelic with or closely linked to the HbP 
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FIGURE 1. The linkage relationship of the hemoglobin structural loci. The 
position of the Hby locus is unknown. 
structural gene. Excluding the one questionable child, if the thalassemia 
gene is not an allele of the HbP structural locus, then the absence of re- 
combinant phenotypes among 35 offspring is consistent with linkage within 
a t  most 10 map units a t  the 0.05 probability level. Although relatively 
little data have been published regarding the Hb Az levels in these families, 
that  which is available, including the families tabulated in this report, 
indicates that  the amount of Hb AZ is increased in the thalassemia heter- 
ozygotes. Thus we have both chemical and genetic evidence to support the 
concept of P-thalassemia. 
P-thalassemia has also been observed in combination with the minor 
component Hb Az' (or Hb Bz). In one large three-generation family the 
8-thalassemia and HbaAz' genes were transmitted in the coupling phase 
with no crossing over in eleven opportunities." Moreover, whether the 
thalassemia and Hb A?' genes are in the coupling or repulsion phase, both 
components are present in twice the proportion normally encountered in 
an uncomplicated AzAz' heterozygote.'" I:' I shall return later to the signif- 
icance of this observation. 
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The concept of a-thalassemia has evolved from chemical evidence that  
n-polypeptide chain synthesis is depressed in persons with hemoglobin H 
disease, also referred to as Hb H-thalassemia. These individuals, in addi- 
tion to having the clinical picture of thalassemia intermedia, possess unique 
erythrocytic inclusion bodies" which a re  due to the instability of the 
Hb H molecule.'.' In affected persons Hb Bart's is also present in varying 
proportions.l0 In infants the amount observed is age dependent, reflecting 
the disappearance of Hb F with age."."' The demonstration that Hb H is 
composed of four normal P-polypeptide chains ( P A )  2'i and Hb Bart's of 
four v-chains ( Y " )  24 has led to the hypothesis that  the thalassemia gene (s  ) 
involved in Hb k-disease results in a relative deficiency of a-chains, the 
excess PA- and YF-dimers polymerizing into the abnormal homogeneous 
tetrame;. The tialassemia t ra i t  associated with Hb H-disease as well 
as the disease itself is characterized by normal or subnormal amounts 
of Hb &.25-27 
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Chemical evidence provides a striking analogy between the effect of the 
a- and P-thalassemia genes on the Hba and HbP structural mutants, re- 
spectively. One individual with Hb'. and two with Hbea in addition to 
an a-thalassemia gene have been describedZR'"o in whom the amount of 
abnormal hemoglobin present is of the order of 70 per cent. In both of the 
latter cases Hb H or Bart's Hb were present as well as a diminished 
amount of Hb Az, serving to identify the thalassemia clearly as of the 
a-type. Despite this chemical evidence there is still no direct genetic evi- 
dence for linkage of the a-thalassemia and Hba loci. This must come from 
studies of the offspring of matings of appropriate double heterozygotes 
with normal spouses. 
The genetics of hemoglobin H-disease are more complex than that of 
the P-thalassemia syndromes. In the first family reported with Hb H- 
disease, one parent of the affected individuals had hematologic evidence 
of mild thalassemia, the other parent was apparently normal. This led to 
postulation that the gene for Hb H was expressed only upon a background 
of thalassemia.Y1*X' To date 22 families have been described in which off- 
spring have Hb H-disease and in which both parents have been studied 
and found not to have Hb H-disease. In eleven of these families both 
parents show some hematologic evidence of thalassemia,~s.zl,'i'l.~R in ten only 
one parent had any evidence,l'l.''s,:'"ii and in one family both parents ap- 
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peared normal.’5 The presence of minimal evidence for thalassemia in both 
parents of so many persons with Hb H-disease suggests that  affected in- 
dividuals have two thalassemia genes.’”.“-“ It also suggests that  in those 
families in which only one parent is affected, the t ra i t  is completely re- 
cessive in the phenotypically normal parent. This situation is not unlike 
that confronting Nee1 in his contemplation of the genetics of sickle cell 
anemia in 1947.1” 
Are two different a-thalassemia genes involved, or does this represent 
variable expression of a single gene? If Hb H-disease is due to two allelic 
a-thalassemic genes, one of which is associated with demonstrable mor- 
phologic abnormalities and the other completely recessive, and if these are 
present in a population a t  frequencies q and r, respectively, and if the 
frequency of the remaining “wild type” alleles is taken as p, the ratio of 
matings resulting in Hb H-disease offspring in which both parents, one 
parent, or neither parent has evidence of a-thalassemia is 4p2q2 :8pzqr :4p2r2, 
respectively. This reduces to qz:2qr:r2. Thus if the “visible” allele is twice 
as common as the recessive one (q = Br), the ratio of respective parents 
would be 4:4:1, not unlike that  reported to date. The distribution of such 
matings cited from the literature cannot be taken too seriously, however, 
because of the diversity of ethnic groups from which the families were 
drawn and because of the biases inherent in case reporting. Nevertheless, 
inequality of the frequency of two alleles will explain the above mentioned 
discrepancies in family data. On the other hand, in five families Hb H- 
disease has been reported in offspring and one parent; the other parent 
was shown to be noma],211. :I% :$!I. 4.5.47 suggesting that it is due to a dominant 
gene. Taken a t  face value, these families would seem to contradict the 
family data referred to previously. Since Hb H-disease is not uncommon 
in southeast Asia, however, the assumption that the phenotypically normal 
parent is indeed genotypically normal may be unwarranted. Moreover, in 
the families described in which Hb H-disease is present in parents and 
offspring, consanguinity apparently has not been considered. 
Further evidence that  Hb H-disease is due to two recessive or nearly 
recessive genes is provided by some studies of informative families pre- 
sented by Virginia Minnich, myself, and our colleagues in ThailandSR,’R 
and summarized in TABLE 2. Five families were ascertained through a 
child who had severe hypochromic, microcytic hemolytic anemia. These 
children had approximately seven gm. per cent hemoglobin, splenomegaly, 
and the hemoglobin electrophoretic pattern consisted of approximately 
15 per cent Hb E, 10 per cent Bart’s Hb, and the remainder Hb A. The 
Hb E component was fingerprinted and found not to be largely Hb A2. 
Among 13 children there were six with this phenotype, Among the five 
families there were also two children with Hb H disease, having approxi- 
mately 15 per cent Hb H and detectable amounts of Hb Bart’s. One child’s 
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FIGURE 2. Schematic interpretation of the family data presented in TABLE 2 
in which one parent has HbP E trait-a-thalassemia trait and the other a-thalas- 
semia trait. The black quadrants represent a HbPE gene, the dot an a-thalassemia. 
White quadrants represent the normal allele. Offspring with simple Hb E trait 
were expected but not observed. 
blood contained 28 per cent Hb  E. Two children were normal and two had 
minimal erythrocytic morphologic evidence of thalassemia minor. One 
parent of each family possessed HbEP, but in the three parents in which 
i t  was measured the amount of Hb  E varied between only 21 and 25 per 
cent. The other hematologic abnormalities in this parent were consistent 
with simple Hb E trait. In  the blood of the other parent in four  of the  
families there was minimal morphologic evidence fo r  thalassemia. The 
amount of Hb  A2 present was normal in two and low in two. The inter- 
pretation of these families, shown schematically in the  pedigree of FIGURE 
2, is t ha t  the parents (and one child) with Hb  E values below 30 per cent, 
at the lower limit of the  range observed in heterozygotes, a r e  heterozygous 
for  an  a-thalassemia gene as 
11.5 
well as for Hb"P. The other parent also has 
7Y 5Y I 4Y 2Y . _  . -  
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FIGURE 3. Interpretation of a family in which the mother has honiozygous 
Hb E disease and the father Hb H-disease, interpretated as due to two a-thalas- 
semia genes. The figures to the left of each symbol refer to the total hemoglobin 
level, those above to the person's age. Symbols as in FIGURE 2. 
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an  a-thalassemia gene. The children with even less Hb  E and, in addition, 
Hb  Bart's have two thalassemia genes in addition to Hb"P. The children 
with Hb  H-disease possess two a-thalassemia genes. If this interpretation 
is correct, the a-thalassemia locus is not closely linked to the HbP structural 
locus since the Hb  E-containing parent could transmit two, one, or none 
of the mutant genes. We have designated the  children having Hb's E 
and Bart's as Hb"P trait-a-thalassemia disease, and the parent containing 
Hb  E a s  Hb"P trait-a-thalassemia trait (TABLE 2 ) .  We should have ob- 
served some children with simple Hb E t ra i t  having more than 30 per cent 
Hb  E, but in this small series none were found. 
Another family in which one parent had Hb H-disease and the other 
homozygous Hb E disease (FIGURE 3 )  was also consistent with this inter- 
pretation. All four children produced from this union had Hb E t ra i t  with 
H b  E concentrations at the  low end of the  range, two having 22 per cent 
and two having 28 per cent. We have suggested tha t  the parent with Hb  H 
had two different a-thalassemia genes ( t l t z  ) which suppress the amount 
of Hb E present in the offspring to different degrees. Extension of these 
studies may provide the  most direct evidence for  the existence of two 
a-thalassemia alleles. 
The effect of t he  proposed a-thalassemia genes in these families is shown 
in FIGURE 4. In  these histograms the blood of normal individuals is shown 
as possessing seven gm. per cent each of a- and P-polypeptide chains, re- 
spectively. In  Hb H-disease (a-thalassemia disease ) characterized by 10.4 
gm. per cent hemoglobin and 15 per cent Hb  H,  a-chains a re  decreased, 
but the total amount of P-chains is also decreased to six gm. per cent. In  
the  Hb  E-trait individual the amount of non-a-chains is distributed be- 
tween PE- and PA-chains. In  Hb  E trait-0-thalassemia t r a i t  fewer PE-chains 
a re  present but the  amount of PA- is increased. A similar phenomenon has 
been observed in the so-called non-interacting sickle cell-thalassemia fam- 
ily described by Cohen et  al.'"' in which the  Hb  A2 was not increased but 
only 22 t o  27 per cent of the hemoglobin was Hb S. In  critical families 
these genes also segregate independently (TABLE 1 ) .  In HbEP trait-a-thalas- 
semia a- and PA-chains are depressed but the PE-chain content i s  dispro- 
portionately lower. Despite the increase of y-chains as Hb  Bart's, the total 
amount of non-a-chains is still diminished. Thus the a-thalassemia genes 
exert an  effect on the non-linked HbP locus, This is not unlike the  action 
of the P-thalassemia gene of the HbaA2 and HbaA" alleles in the  trans a s  
well as in the cis configuration. By analogy, one would anticipate tha t  the  
P-thalassemia genes when combined with the a-chain structural mutants 
will depress the amount of abnormal hemoglobin present. 
There i s  a tendency now to equate these effects with diminished rate of 
hemoglobin synthesis. If erythrocyte lifespan is very short  in these anemic 
individuals, net hemoglobin synthesis may be greatly increased. Likewise, 
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if the hemoglobin components are  not homogeneously distributed among 
erythrocytes - and there is  some evidence suggesting that  Hb F is not5" - 
and if erythrocyte lifespan is not uniform, net relative rate of synthesis 
of a give abnormal hemoglobin may be high although in whole blood it 
may constitute a smaller proportion of the hemoglobin present. 
Another intriguing question is that of the relationship between Bart's Hb 
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FIGURE 4. The effect of a-thalassemia genes on the absolute amount of 
hemoglobin circulating a s  (I-, P-, and ?-polypeptide chains, respectively. The 
contribution of normal fetal hemoglobin has been neglected for simplicity. 
Tuchinda et ul." and Lie-Injo'" have found small amounts of Hb Bart's in 
about five per cent of cord bloods in southeast Asia. In this country Min- 
nich et al." found Bart's Hb in approximately seven per cent of cord 
bloods of Negroes using starch block electrophoresis. Weatherall has found 
5 to 10 per cent of i t  in approximately two per cent of a series of 1000 
cord bloods of Negroes and trace amounts in nearly all cord bloods.g2 Both 
author8 have produced evidence for thalassemia among parents and other 
relatives of the infants with the larger amounts. Hb Bart's has also been 
found in 10 per cent of newborn infants in Nigeria."' Yet, outside of South- 
east Asia Hb H-disease is rare. Weatherall has quite properly postulated 
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that two genes are necessary for Hb H-disease and only one of these is 
prevalent in the American Negro.'2 Lie-Injo has described in stillborn 
fetuses erythroblastosis accompanied by large amounts of Hb Bart's and 
has suggested that this is due to homozygosity for a-thalassemia genesas' 
This raises the possibility that some but not necessarily all of the homo- 
zygotes for the gene responsible for the Bart's Hb of the newborn Negro 
are not seen because of in utero lethality. Are the two postulated genes 
responsible for Hb H allelic or not? The only clear test of this a t  present 
is a study of offspring of Hb H-disease persons married to normal spouses. 
Because of the probability that the heterozygous state of the a-thalassemia 
gene is undetectable in many instances and because of the apparently high 
probability in Southeast Asia that phenotypically normal persons may be 
in fact a-thalassemia heterozygotes, this approach is not likely to be a 
critical one. Indeed, differentiating multiple allelic inheritance from genes 
distributed among multiple loci, when the genotypes cannot be precisely 
identified, constitutes one of the more difficult problems in human genetics. 
Numerous atypical patterns of abnormalities have been described and 
classed as P-thalassemia. Experience with similar modifier genes in other 
organisms suggests that we can expect all possible variations among thalas- 
semia genes which ultimately will prove to be linked with the HbP locus. 
Caution might therefore be used before considering thalassemia without 
increased amounts of Hb A2 as a-thalassemia. To date, the only reliable 
criterion for a-thalassemia is the presence of Bart's Hb and perhaps inter- 
action with structural mutants. 
From the facts a t  hand can we come to any conclusions regarding the 
basic nature of thalassemia? Before attempting to  do so a brief summary 
of current concepts of 'cellular control of protein synthesis is in order. 
Based upon biochemical studies and genetic fine structure mapping in 
bacteria, Jacob and Monod'5 have postulated the existence of "operator" 
genes which appear to control the expression of blocks of juxtaposed struc- 
tural genes. The operator gene exerts its effect upon structural genes in 
the same chromosome or DNA strand, i.e., in the cis position. In a manner 
not yet understood it controls either the rate at  which the information 
embodied in the structural genes is transcribed into a ribonucleotide re- 
ferred to as messenger ribose nucleic acid, or i t  governs the rate a t  which 
the structural proteins are synthesized on the messenger RNA template. 
The operator is in turn repressed by a molecule, currently believed to be 
a protein, which is under the control of another genetic locus which may 
not even be linked to the operon, as the block of operator plus structural 
genes is designated. As indicated earlier, there is ample evidence to indi- 
cate that the Hba and HbP structural loci are closely linked. In an inherited 
entity referred to as the high fetal hemoglobin gene heterozygotes retain 
approximately 30 per cent of Hb F into adulthood without any other 
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hematologic abnormality. A homozygote for this gene lacks both hemo- 
globins A2 and A.53 This observation has led Nee]" and Motulsky" to 
suggest that  the high F gene (OF in FIGURE 5 )  may be equated with the 
operator gene of the microbial systems, in which a mutation has resulted 
in a failure to synthesize both 8 -  and P-chains. Deletion of the HbP and 
Hba loci is still an equally likely possibility, however. 
Itano"s and Ingram and Stretton"' have postulated that thalassemia may 
be the result of a "silent substitution" of the hemoglobin polypeptide chain 
in which an amino acid is substituted by one of like charge and thus not 
detected electrophoretically. Although the contrary evidence is not over- 
whelming, enough exists to force H. A. Itano (see p. 816) to speculate 
that the diminished rate of hemoglobin synthesis in thalassemia is due 
to degeneracy"c of the a- or P-chain structural code. Ingram has likewise 
advanced an alternate hypothesis (see p. 485). I have summarized evidence 
indicating that 0-thalassemia is not linked to the HbP structural locus 
Hb a Th a 
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FIGURE 5. Hypothetical linkage relationships between the thalassemia and 
hemoglobin structural loci. The small horizontal arrows indicate polarity of the 
respective chromosomes corresponding to the direction of polypeptide chain 
synthesis. The dotted arrows represent regulation of the indicated chain syn- 
thesis by a hypothetical repressor substance (or by lack of an inducer). 
despite exerting an apparently direct effect upon it. This is in conflict with 
the hypothesis of Name5' which attributes a-thalassemia to a fusion gene 
formed by unequal crossing over involving the HbP, Hba, and the pre- 
sumably closely linked Hbu loci. Since the total hemoglobin level in P- 
thalassemia is depressed only approximately 15 per cent, but the total 
amount of Hb AZ is doubled, the increase in Hb Az appears absolute rather 
than relative to the decrease in Hb A. Moreover, P-thalassemia appears 
to enhance the expression of both the HbaA2 and HbP':  genes in individuals 
heterozygous a t  both loci. Thus it influences genes in the trans position 
or repulsion phase as well as the cis. Thalassemia, therefore, appears to 
function as the repressor gene of Jacob and Monod, despite the fact that  
P-thalassemia is closely linked if not allelic with the HbP or Hba structural 
loci. In FIGURE 4 the author has located the P-thalassemia locus between 
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the Hbs and HbP structural loci, primarily because the  hematologic mani- 
festations of H b  Lepore can be explained as a deletion of t ha t  locus. This 
utilizes clinical evidence to  answer a genetic question, however, and until 
linkage information appears, the  relationship between the structural loci 
and thalassemia is conjectural. This still tells us nothing about the nature 
of thalassemia. 
Robin M. Bannerman reviews the evidence tha t  porphyrin metabolism 
is apparently disturbed in thalassemia (p. 503). Paul A. Marks (p. 513 ) 
and V. M. Ingram (p. 485) present evidence tha t  the  ribosomes of thalas- 
semic erythroblasts do not function normally. Can all of these aspects be 
integrated with the genetic observations? Are these lesions primary or 
merely secondary manifestations of “sick cells”? The fact t ha t  P-thalas- 
semia genes can be more readily identified than  a-thalassemia genes with 
the techniques at our disposal may be a hint t ha t  the two entities produce 
hypochromic anemia and the electrophoretic interactions by entirely dif- 
ferent mechanisms. I t  seems to me tha t  we will not be able to determine 
whether a given chemical abnormality represents the primary biochemical 
effect of the thalassemia gene until we can correlate these abnormalities 
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